Nazareth College postpones J&J vaccine clinics
Pause requested by CDC and FDA
Rochester, NY (04/13/2021) — This letter was sent to Nazareth College students, faculty, and staff this morning, April 13:
_______________________________________________________________________
Dear students, faculty and staff,
This morning, the Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC) recommended a pause in administration of Johnson & Johnson (J&J) Janssen COVID-19 vaccine. Due to this recommendation and out of an abundance of caution, the Nazareth on-campus vaccine clinics scheduled for students today from noon to 7 p.m. and Wednesday from 9 a.m. - 3 p.m. are postponed until further notice.
From an Associated Press report this morning:
In a joint statement Tuesday, the Centers for Disease Control and Prevention and the Food and Drug Administration said they were investigating unusual (blood) clots in six women that occurred 6 to 13 days after vaccination. The clots were observed in the sinuses of the brain along with reduced platelet counts - making the usual treatment for blood clots, the blood thinner heparin, potentially "dangerous."
More than 6.8 million doses of the J&J vaccine have been administered in the U.S., the vast majority with no or mild side effects. The other two authorized vaccines, from Moderna and Pfizer, make up the vast share of COVID-19 shots administered in the U.S. and are not affected by the pause.
Johnson & Johnson points out, "At present, no clear causal relationship has been established between these rare events and the Janssen Covid-19 vaccine."
Given the data and the extremely low incidence rate, there is no reason to panic if you've received the J&J vaccine. The data demonstrates that the benefits of receiving the vaccine far outweigh the risks.
Students, if you are concerned about symptoms or your health in general, please contact Health and Counseling Services at 585-389-2500. Faculty and staff, if you have concerns, contact your health care provider.
We will hold our current vaccine supply until we are advised otherwise. We will continue to update the community as we work with the Monroe County Department of Health and the CDC and we have more information to share.
Sincerely,
Susan Quinn
Director, Health and Counseling
Nazareth College
Julie Long, Chief Public Relations Officer | (585) 389-2456 | (585) 781-8186 (c) | jlong2@naz.eduShare this Story
Recent News
- Nazareth University named to The Princeton Review's Mental Health Services Honor Roll for 2027
- Nazareth University celebrates the Inauguration of 11th President, Maureen F. Finney, Ed.D., PA-C
- The Inauguration of Nazareth University's 11th President Maureen Finney: Saturday, Oct. 24
- Nazareth's ongoing commitment to student mental health receives new national grant
- Nazareth University hosts first-ever Weekend of the Arts with Breaking Bad, Star Wars star Giancarlo Esposito headlining
- Nazareth University professors passionate about using play as a vehicle for learning are now training other universities
- Nazareth University students are preserving the stories and traditions of Rochester's Italian-American community by conducting oral history interviews, Oct. 4
- U.S. News & World Report ranks Nazareth University a 2027 Best College: Top 30 Private School, Top 50 University in Northeast, and Best Value School
- Nazareth University launches women's health nurse practitioner master's degree for in-demand jobs
- Nazareth University awarded grant to lead 9/11 Day service project benefiting Oak Tree Food Pantry on campus